Home

GLENN L MD COOPER

CIK 1046351 · See Remarks · last filed 2019-06-19

GLENN L MD COOPER is a corporate insider who has filed 22 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for RGEN, was dated Jun 19, 2019. Across all open-market trades the lifetime net is −$515.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.0M across reported positions. 4 SEC filings were submitted jointly with Fortress Biotech, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.01M

Companies

3

Total Filings

22

Lifetime Open-Market Net

-$515.4K

Filer Profile

Reported Address
C/O 99 HAYDEN AVE
1 LEDGEMONT CENTER
LEXINGTON, MA 02173
Formerly Known As
COOPER GLEN L MD (1997–1999)
Related Filers
Fortress Biotech, Inc. — 4 joint filings, latest 2012-12-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RGEN Director 59,709 $167.60 $10.01M -$583.7K 15 2019-06-19
Fortress Biotech, Inc. (CNDO) Delisted See Remarks 43,811 — — $68.3K 3 2012-12-03
IDEV CEO 0 $93.41 $0 $0 4 2009-02-25

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-06-19 RGEN Mixed +19,000 -$214.7K EDGAR
2019-05-28 RGEN Sell (S) −5,000 -$334.7K EDGAR
2019-05-17 RGEN Grant (A) +923 $0 EDGAR
2018-05-17 RGEN Grant (A) +1,486 $0 EDGAR
2017-05-22 RGEN Grant (A) +1,206 $0 EDGAR
2016-05-13 RGEN Grant (A) +1,763 $0 EDGAR
2015-11-12 RGEN Grant (A) +1,000 $26.6K EDGAR
2015-05-26 RGEN Grant (A) +1,019 $0 EDGAR
2013-05-16 RGEN Grant (A) +5,342 $0 EDGAR
2012-12-03 Fortress Biotech, Inc. (CNDO) Delisted Buy (P) +3,811 $15.3K EDGAR
Showing 1–10 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.